| For: | |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i4/441.htm |
| Number | Citing Articles |
| 1 |
FAHE JI, DONGCHU MA, ZHAOZHE LIU, XIAODONG XIE. Rosiglitazone amplifies the sensitivity of docetaxel and reduces the expression of CD44v6. Oncology Letters 2014; 7(4) doi: 10.3892/ol.2014.1824
|
| 2 |
İlhan Elmaci, Meric A Altinoz. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme. Biochemical Genetics 2016; 54(5) doi: 10.1007/s10528-016-9754-9
|
| 3 |
W. Xu, X. Liu, Z. Yu, W. Zhang, Q. Zheng, Z. Liu. MRI features of pancreatic intraductal papillary mucinous neoplasms associated with invasive carcinoma. Clinical Radiology 2018; 73(10) doi: 10.1016/j.crad.2018.06.001
|
| 4 |
Jihan A. Youssef, Mostafa Z. Badr. Peroxisome Proliferator-Activated Receptors. 2013; doi: 10.1007/978-1-62703-420-3_5
|
| 5 |
JING ZHANG, WEI YANG, DUANYUN ZHAO, YUN HAN, BO LIU, HUA ZHAO, HONGBO WANG, QUANZHONG ZHANG, GUANGMING XU. Correlation between TSP-1, TGF-β and PPAR-γ expression levels and glioma microvascular density. Oncology Letters 2014; 7(1) doi: 10.3892/ol.2013.1650
|
| 6 |
Yi-Fan Dang, Xiao-Ning Jiang, Fu-Lian Gong, Xiu-Li Guo. New insights into molecular mechanisms of rosiglitazone in monotherapy or combination therapy against cancers. Chemico-Biological Interactions 2018; 296 doi: 10.1016/j.cbi.2018.09.019
|
| 7 |
Peng Zhang, Yisheng Sun, Lei Shi, Dekang Sun, Lin Wang, Dongdong Feng, Chao Ding. Effect of isorhamnetin on carbonic anhydrase IX expression and tumorigenesis of bladder cancer by activating PPARγ/PTEN/AKT pathway. Tissue and Cell 2023; 82 doi: 10.1016/j.tice.2023.102048
|
| 8 |
Annika Bundscherer, Christian Hafner. From Molecular to Modular Tumor Therapy. 2010; doi: 10.1007/978-90-481-9531-2_24
|
| 9 |
Yuhan Dai, Yuling Yang, Haiyang Li, Yinggui Wang, Yong Wang, Yaqiu Lin, Lian Huang, Zhanyu Du, Hua Xiang, Changhui Zhang, Jiangjiang Zhu. PLIN5 Promotes Lipid Reconstitution in Goat Intramuscular Fat via the PPARγ Signaling Pathway. Biology 2025; 14(11) doi: 10.3390/biology14111547
|
| 10 |
Athina Stravodimou, Gianluigi Mazzoccoli, Ioannis A. Voutsadakis. Peroxisome Proliferator-Activated Receptor Gamma and Regulations by the Ubiquitin-Proteasome System in Pancreatic Cancer. PPAR Research 2012; 2012 doi: 10.1155/2012/367450
|
| 11 |
Jihan Youssef, Mostafa Badr. Peroxisome proliferator-activated receptors and cancer: challenges and opportunities. British Journal of Pharmacology 2011; 164(1) doi: 10.1111/j.1476-5381.2011.01383.x
|
| 12 |
Khanh Vu, Naifa Busaidy, Maria E. Cabanillas, Marina Konopleva, Stefan Faderl, Deborah A. Thomas, Susan O'Brien, Kristine Broglio, Joe Ensor, Carmen Escalante, Michael Andreeff, Hagop Kantarjian, Victor Lavis, Sai-Ching Jim Yeung. A Randomized Controlled Trial of an Intensive Insulin Regimen in Patients With Hyperglycemic Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma and Leukemia 2012; 12(5) doi: 10.1016/j.clml.2012.05.004
|
| 13 |
Belete Biadgo, Molla Abebe. Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review. The Korean Journal of Gastroenterology 2016; 67(4) doi: 10.4166/kjg.2016.67.4.168
|
| 14 |
Zhuo Xu, Shao-Hua Meng, Jian-Guo Bai, Chao Sun, Li-Li Zhao, Rui-Feng Tang, Zhao-Lin Yin, Jun-Wei Ji, Wei Yang, Guang-Jun Ma. C/EBPα Regulates FOXC1 to Modulate Tumor Growth by Interacting with PPARγ in Hepatocellular Carcinoma. Current Cancer Drug Targets 2020; 20(1) doi: 10.2174/1568009619666190912161003
|
| 15 |
Alessandra Dicitore, Michele Caraglia, Germano Gaudenzi, Gloria Manfredi, Bruno Amato, Daniela Mari, Luca Persani, Claudio Arra, Giovanni Vitale. Type I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-γ (PPAR-γ): At the cross-road of pancreatic cancer cell proliferation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014; 1845(1) doi: 10.1016/j.bbcan.2013.11.003
|
| 16 |
Nicole Wagner, Kay-Dietrich Wagner. PPARs and Angiogenesis—Implications in Pathology. International Journal of Molecular Sciences 2020; 21(16) doi: 10.3390/ijms21165723
|
| 17 |
Nicole Wagner, Kay-Dietrich Wagner. Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer. Cells 2022; 11(15) doi: 10.3390/cells11152432
|
| 18 |
YANG ZHAO, JIANHUA GAO, FENG LU. Human adipose-derived stem cell adipogenesis induces paracrine regulation of the invasive ability of MCF-7 human breast cancer cells in vitro. Experimental and Therapeutic Medicine 2013; 6(4) doi: 10.3892/etm.2013.1237
|
| 19 |
Bianka Bojková, Peter Orendáš, Peter Kubatka, Martin Péč, Monika Kassayová, Terézia Kisková, Karol Kajo. Positive and negative effects of glitazones in carcinogenesis: Experimental models vs. clinical practice. Pathology - Research and Practice 2014; 210(8) doi: 10.1016/j.prp.2014.06.003
|
| 20 |
Christina K. Cramer, Natalie Alphonse-Sullivan, Scott Isom, Linda J. Metheny-Barlow, Tiffany L. Cummings, Brandi R. Page, Doris R. Brown, Arthur W. Blackstock, Ann M. Peiffer, Roy E. Strowd, Stephen Rapp, Glenn J. Lesser, Edward G. Shaw, Michael D. Chan. Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial. Journal of Cancer Research and Clinical Oncology 2019; 145(2) doi: 10.1007/s00432-018-2791-5
|
| 21 |
Jingxuan Pan, Chun Chen, Yanli Jin, Enrique Fuentes-Mattei, Guermarie Velazquez-Tores, Juliana Maria Benito, Marina Konopleva, Michael Andreeff, Mong-Hong Lee, Sai-Ching J. Yeung. Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells. Cell Cycle 2012; 11(12) doi: 10.4161/cc.20770
|
| 22 |
Yin-Hsun Feng, Guermarie Velazquez-Torres, Christopher Gully, Jian Chen, Mong-Hong Lee, Sai-Ching Jim Yeung. The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. Journal of Cellular and Molecular Medicine 2011; 15(4) doi: 10.1111/j.1582-4934.2010.01083.x
|
| 23 |
Mani Roshan-Moniri, Michael Hsing, Miriam S. Butler, Artem Cherkasov, Paul S. Rennie. Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers. Cancer Treatment Reviews 2014; 40(10) doi: 10.1016/j.ctrv.2014.10.005
|
| 24 |
Emir Begagić, Amina Džidić-Krivić, Hakija Bečulić, Ragib Pugonja, Adnana Ljevaković, Binasa Bašić, Adem Nuhović, Elma Milanović, Semir Hadžić, Emir Bećirović, Lemana Buljubašić, Minela Bećirović, Mirza Pojskić. Glucose and antidiabetic therapy in temozolomide resistance in glioblastoma. World Journal of Clinical Oncology 2025; 16(8): 108112 doi: 10.5306/wjco.v16.i8.108112
Abstract(243) |
Core Tip(184) |
Full Article(HTML)(861)
|
Full Article (PDF)-4014K(132)
|
Full Article with Cover (PDF)-4291K(79)
|
Full Article (XML)-155K(70)
|
Audio-146K(14)
|
Peer-Review Report-235K(61)
|
Answering Reviewers-67K(81)
|
Supplementary Material-700K(62)
|
Times Cited (1)
|
Total Visits (1625)
|
Open
|
| 25 |
Hui-Min Chen, Ding-Guo Zhang, Jin-Xiz Wu, Dong-Sheng Pei, Jun-Nian Zheng. Ubiquitination of p53 is Involved in Troglitazone Induced Apoptosis in Cervical Cancer Cells. Asian Pacific Journal of Cancer Prevention 2014; 15(5) doi: 10.7314/APJCP.2014.15.5.2313
|
| 26 |
P. J. Simpson-Haidaris, S. J. Pollock, S. Ramon, N. Guo, C. F. Woeller, S. E. Feldon, R. P. Phipps. Anticancer Role of PPARγAgonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes. PPAR Research 2010; 2010 doi: 10.1155/2010/814609
|
| 27 |
MINGZHONG RUI, ZHANPING HUANG, YING LIU, ZIYAN WANG, RUI LIU, JINXIANG FU, HAIWEN HUANG. Rosiglitazone suppresses angiogenesis in multiple myeloma via downregulation of hypoxia-inducible factor-1α and insulin-like growth factor-1 mRNA expression. Molecular Medicine Reports 2014; 10(4) doi: 10.3892/mmr.2014.2407
|
| 28 |
Joo-In Park, Jong-Young Kwak. The Role of Peroxisome Proliferator-Activated Receptors in Colorectal Cancer. PPAR Research 2012; 2012 doi: 10.1155/2012/876418
|
| 29 |
Emily Yun-Chia Chang, Yi-Cheng Chang, Chia-Tung Shun, Yu-Wen Tien, Shu-Huei Tsai, Siow-Wey Hee, Ing-Jung Chen, Lee-Ming Chuang, Ajay Pratap Singh. Inhibition of Prostaglandin Reductase 2, a Putative Oncogene Overexpressed in Human Pancreatic Adenocarcinoma, Induces Oxidative Stress-Mediated Cell Death Involving xCT and CTH Gene Expressions through 15-Keto-PGE2. PLOS ONE 2016; 11(1) doi: 10.1371/journal.pone.0147390
|
| 30 |
Pengren Luo, Jinhong Yang, Lipeng Jian, Jigen Dong, Shi Yin, Chao Luo, Shuai Zhou. Knockdown of PGBD5 inhibits the malignant progression of glioma through upregulation of the PPAR pathway. International Journal of Oncology 2024; 64(5) doi: 10.3892/ijo.2024.5643
|
| 31 |
Přemysl Frič, Jan Škrha, Aleksi Šedo, Petr Bušek, Klára Kmochová, Martin Laclav, Svatopluk Solař, Bohuš Bunganič, Miroslav Zavoral. Early pancreatic carcinogenesis – risk factors, early symptoms, and the impact of antidiabetic drugs. European Journal of Gastroenterology & Hepatology 2016; 28(7) doi: 10.1097/MEG.0000000000000646
|
| 32 |
Roberta Rapuano, Antonella Mercuri, Sabrina Dallavalle, Salvatore Moricca, Antonio Lavecchia, Angelo Lupo. Cladosporols and PPARγ: Same Gun, Same Bullet, More Targets. Biomolecules 2024; 14(8) doi: 10.3390/biom14080998
|
| 33 |
Soyeon Kim, Jae-Jung Lee, Dae Seog Heo. PPARγ ligands induce growth inhibition and apoptosis through p63 and p73 in human ovarian cancer cells. Biochemical and Biophysical Research Communications 2011; 406(3) doi: 10.1016/j.bbrc.2011.02.052
|
| 34 |
Wanbo Xu, Xiaojin Liu, Jiawen Zhang, Li Yang. Intraductal Papillary Mucinous Neoplasms of the Pancreas. Academic Radiology 2017; 24(5) doi: 10.1016/j.acra.2016.12.013
|
| 35 |
Andrea Galli, Sara Tempesti, Mirko Tarocchi, Simone Polvani. Nuclear receptors and pathogenesis of pancreatic cancer. World Journal of Gastroenterology 2014; 20(34): 12062-12081 doi: 10.3748/wjg.v20.i34.12062
|
| 36 |
Navriti Chadha, Om Silakari. Key Heterocycle Cores for Designing Multitargeting Molecules. 2018; doi: 10.1016/B978-0-08-102083-8.00005-4
|
| 37 |
Yan-qiu Ou, Wen-bo Zhu, Yan Li, Peng-xin Qiu, Yi-jun Huang, Jun Xie, Song-min He, Xiao-ke Zheng, Tian-dong Leng, Dong Xu, Guang-mei Yan. Aspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicity. Acta Pharmacologica Sinica 2010; 31(1) doi: 10.1038/aps.2009.172
|
| 38 |
Adeline Guais, GianFranco Baronzio, Edward Sanders, Frédéric Campion, Carlo Mainini, Giammaria Fiorentini, Francesco Montagnani, Mahsa Behzadi, Laurent Schwartz, Mohammad Abolhassani. Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report. Investigational New Drugs 2012; 30(1) doi: 10.1007/s10637-010-9552-x
|